[mkdf_section_title position=”” show_separator=”yes” separator_position=”center” title_tag=”” disable_break_words=”no” title=”Pubblicazioni 2017″ holder_padding=”13px”]

Mechanisms and risk factors of thrombosis in cancer.

Falanga A, Russo L, Milesi V, Vignoli A.

Crit Rev Oncol Hematol. 2017;118:79-83.

Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.

D’Alessio A, Marchetti M, Tartari CJ, Russo L, Cecchini S, Lambregts KWFM, di Mauro D, Falanga A.

Cancer Invest. 2017;35(7):490-499.

Predicting APL lethal bleeding in the ATRA era.

Falanga A.

Blood. 2017;129(13):1739-1740.